- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies
Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
33
2 new
Companies with a Value score of at least 3, ordered by Value score
33 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PPGN | CHF 21.95 | -6.4% | 32.7% | CHF 724.0m | CHF 36.16 | PS2.4x | E64.9% | 0% | ||
TECN | CHF 212.20 | -0.4% | -40.3% | CHF 2.7b | CHF 283.83 | PE26.9x | E13.9% | 1.4% | ||
GALD | CHF 112.54 | -2.7% | n/a | CHF 26.7b | CHF 107.26 | PS6.9x | E36.6% | n/a | ||
000907582 | CHF 226.36 | 0% | n/a | CHF 145.8b | CHF 229.35 | PE19.3x | E5.7% | 3.1% | ||
000943981 | CHF 141.72 | 2.0% | 2.9% | CHF 375.9b | CHF 153.06 | PE26.7x | E8.4% | 3.2% | ||
0QF | CHF 184.33 | 0% | 40.6% | CHF 53.4b | CHF 293.47 | PE6.4x | E-15.5% | n/a | ||
UNC | CHF 77.91 | 0% | n/a | CHF 16.3b | CHF 87.27 | PE38.8x | E24.8% | 1.5% | ||
IDIA New | CHF 0.73 | 0.6% | -46.9% | CHF 137.8m | CHF 1.00 | PS1.2x | E17.8% | n/a | ||
CSJ | CHF 158.89 | 0% | -1.8% | CHF 124.4b | CHF 197.42 | PE28.8x | E12.9% | 1.6% |